More serious and researched topics
I have a confession to make: I don’t really like economists. It goes back to my time as as undergrad student, I suppose. I was forced to take three economics classes and I still resent the university for it (no way they are ever getting donations from me). Those were the most dreadful, boring and […]
Here’s how to make a quick 400% return with minimal risk thanks to the Halliburton / Baker’s Hughes buyout. Here’s what you’re going to do: When Halliburton buys BHI, you will get 1.12 shares of HAL for every share of BHI you have. You will also get $19.00 in cash. Thus, you are making a […]
**Update 11/25: Rebuying as soon as the downtrend ends. It’s at least worth taking a look. The Habit, a fast-growing burger joint based in the United States, is having its IPO this week, probably on Thursday, and it’s by far one of the most popular upcoming IPOs are the moment. In fact, it’s almost […]
The IPO I’m waiting for the most at the moment is certainly Fibrogen, a biopharmaceutical company about to become public on Friday. Biopharms have done exceptionally well in the last few months, against all expectations, and I am hoping Fibrogen to be even better. But the question remains: how much is Fibrogen worth? Before we begin, […]
Remember when I said there were several outstanding IPO in the pipeline? Well, yeah. Today’s evaluation will be Axalta Coating Systems which boasts its slogan “Built for performance.” As opposed to what? Built for failure? All bad puns aside, what exactly is Axalta Coating Systems? Well, it’s a company that manufactures coating; basically, paint. I’ve […]
